GVB has been acquired by 22nd Century Group (Nasdaq: XXII), Read the Press Release Here
Press Releases Archive - GVB Biopharma

Cart (0 item)

Archives: Press Releases

BUFFALO, N.Y., May 18, 2022 — 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company dedicated to improving human health with reduced nicotine tobacco, hemp/cannabis, and hops advanced plant technology, today announced that it has begun integration of GVB Biopharma…

  • Posted in
  • Comments Off on 22nd Century Group (Nasdaq: XXII) Begins Integration of GVB Biopharma, Creating a Complete, Robust Hemp/Cannabis Platform

BUFFALO, N.Y., May 13, 2022 — 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company dedicated to improving human health with reduced nicotine tobacco, hemp/cannabis, and hops advanced plant technology, today announced the acquisition of privately held GVB Biopharma.

  • Posted in
  • Comments Off on 22nd Century Group (Nasdaq: XXII) Acquires GVB Biopharma, a Leading Hemp/Cannabis Company

LONDON, UK, April 7, 2022 – GVB Biopharma, a biopharmaceutical company specializing in hemp and cannabis-related white-label consumer products, announced today that all of its products remain approved by the Food Standards Agency (FSA) after the organization created stricter market standards for foods containing cannabidiol (CBD) sold in most United Kingdom (UK) countries. On April 1, […]

  • Posted in
  • Comments Off on All GVB Biopharma Products Clear New, Stricter Food Safety Standards in UK

LAS VEGAS, March 30, 2022 — GVB Biopharma, a biopharmaceutical company specializing in hemp and cannabis-related white-label consumer products, announced today that its website has launched sales of cannabigerolic acid isolates, popularly known as CBGa. CBGa is the carboxylic acid form of cannabigerol, known as CBG. It is a precursor molecule to delta-9-tetrahydrocannabinol, one of […]

  • Posted in
  • Comments Off on GVB Biopharma Begins Sales of CBGa Isolate

LAS VEGAS, March 21, 2022 — With validation of its Novel Food application to the FSA, GVB Biopharma continues to strengthen its UK and European activities. GVB is one of the largest US CBD manufacturers and has several modern production facilities. GVB is one of the few true “seed to shelf” suppliers remaining in this space. GVB […]

  • Posted in
  • Comments Off on GVB Biopharma Strengthens European Operations After UK Validation

GRASS VALLEY, Ore., Feb. 1, 2022 — GVB Biopharma, a biopharmaceutical company specializing in hemp and cannabis-related consumer products, announced today that it is experiencing a sizable increase in interest and orders for cannabidiolic acid, a cannabinoid popularly known as CBDa. Since the first month that CBDa sales began at GVB, internal data shows that the […]

  • Posted in
  • Comments Off on GVB Biopharma Sees Cannabidiolic Acid (CBDa) Demand Surge

NEW YORK, Oct. 20, 2021 — GVB Biopharma, the leader in hemp-derived cannabinoid active ingredient production and white label product formulation, announced today that it has been named Leading Manufacturer of the Year at the 2021 New York City White Label Expo. The event, held annually in the fall, acts as a premier showcase and sourcing show […]

  • Posted in
  • Comments Off on GVB Biopharma Awarded Leading Manufacturer of the Year at 2021 NYC White Label Expo

LAS VEGAS, Jan. 12, 2021 — Certification from Major USDA-Accredited Organic Certifier Sets GVB Biopharma Apart from Competition. GVB Biopharma, the leader in hemp-derived cannabinoid active ingredient production and white label product formulation, has received Handling certification from USDA-accredited certifier California Certified Organic Farmers (CCOF). Effective December 22nd, 2020, this prestigious certification does not have an expiration […]

  • Posted in
  • Comments Off on GVB Biopharma Sets Industry Precedent with CCOF Certification

BOCA RATON, Fla., Oct. 13, 2020 — GVB Biopharma, a nutraceutical company specializing in hemp and cannabis-related consumer products, announced today that it has opened its fourth national sales and business development office in Boca Raton, FL. The Boca Raton office is GVB’s third new sales office opened this year, joining its sister offices in Los Angeles, Chicago and Denver. Along with state-of-the-art facilities for […]

  • Posted in
  • Comments Off on GVB Biopharma Opens New Boca Raton Office
CBT Guide

LAS VEGAS, Aug. 6, 2020 — GVB Biopharma, a pharmaceutical company specializing in hemp and cannabis-related consumer products, announced today that it has established the process and infrastructure for producing medicinal products from cannabigerol (CBG). With this venture, GVB Biopharma creates a scientific foundation and professional network for a research and development program for CBG, allowing for […]

  • Posted in
  • Comments Off on GVB Biopharma Begins Cannabigerol (CBG) Studies to Assess Therapeutic Potential

Get in touch today

Ready to Build Your Brand?

12